Kristy Ainslie/pharmacy.unc.edu
Mar 6, 2026, 15:43
Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
Kristy Ainslie, Fred Eshelman Distinguished Professor and Director at University of North Carolina at Chapel Hill, shared a post on LinkedIn:
“Ever wonder about the discovery and FDA approval of your favorite drug carrier? I’ve broken them down and highlighted each advancement – with references!
Enjoy and let me know if think I forgot something.
Part 1 – Living Medicine
Part 2 – Complex Biologics
Part 3 – Inorganic Carriers
Part 4 – Other Carriers
Part 5 – Nucleic Acids and Lipids
Part 6 – Polymers
Part 7 – Proteins
Part 8 – Devices”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care